Allergy medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 25: Line 25:


===Immunotherapy===
===Immunotherapy===
*Desensitization, also known as [[hyposensitization]], is a therapy in which the patient is gradually [[vaccinated|vaccinated]] with increasing doses of the allergen in question. This will either lessen the severity of hypersensitivity or completely remove it. To block excessive IgE production seen in atopys, it depends on the progressive skewing of [[IgG]] antibody production. In a sense, the individual develops resistance to rising quantities of the allergen in question. Immunotherapy has been shown to have a long-term effectiveness and preventive effect in preventing the development of new allergies in studies.<ref name="pmid10963288">{{cite journal |author=Ross RN, Nelson HS, Finegold I |title=Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies |journal=Clinical therapeutics |volume=22 |issue=3 |pages=342–50 |year=2000 |pmid=10963288 |doi=10.1016/S0149-2918(00)80038-7}}</ref>
*Desensitization or [[hyposensitization]] with allergen <ref name="pmid10963288">{{cite journal |author=Ross RN, Nelson HS, Finegold I |title=Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies |journal=Clinical therapeutics |volume=22 |issue=3 |pages=342–50 |year=2000 |pmid=10963288 |doi=10.1016/S0149-2918(00)80038-7}}</ref>
*[[Intravenous]] injection of [[monoclonal antibody|monoclonal]] anti-IgE antibodies [[Omalizumab]]
*[[Intravenous]] injection of [[monoclonal antibody|monoclonal]] anti-IgE antibodies [[Omalizumab]]
*[[Sublingual immunotherapy]]
*[[Sublingual immunotherapy]]

Revision as of 05:14, 25 March 2021

Allergy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Allergies from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Allergy medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Allergy medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Allergy medical therapy

CDC on Allergy medical therapy

Allergy medical therapy in the news

Blogs on Allergy medical therapy

Directions to Hospitals Treating Allergies

Risk calculators and risk factors for Allergy medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]


Overview

The mainstay of treatment for allergy is pharmacological medical therapy.

Medical Therapy


Pharmacotherapy


Immunotherapy

Unproven or Ineffective Treatments

References

  1. Sicherer SH, Leung DY (2007). "Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects". J. Allergy Clin. Immunol. 119 (6): 1462–9. doi:10.1016/j.jaci.2007.02.013. PMID 17412401.
  2. Ross RN, Nelson HS, Finegold I (2000). "Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies". Clinical therapeutics. 22 (3): 342–50. doi:10.1016/S0149-2918(00)80038-7. PMID 10963288.
  3. Terr AI (2004). "Unproven and controversial forms of immunotherapy". Clinical allergy and immunology. 18: 703–10. PMID 15042943.
  4. Altunç U, Pittler MH, Ernst E (2007). "Homeopathy for childhood and adolescence ailments: systematic review of randomized clinical trials". Mayo Clin. Proc. 82 (1): 69–75. PMID 17285788.

Template:WikiDoc Sources